Korean Hair Loss Shampoo Becomes First to Gain Chinese Regulatory Approval
Key Insights
Caron Bio (search)'s C3 Da Balmo Shampoo (search) has become the first Korean hair loss (search) product to receive regulatory approval from China's National Medical Products Administration (search).
The shampoo demonstrated significant clinical efficacy in German trials, showing 54% reduction in hair loss (search) and 10% increase in hair thickness over six months.
This approval enables nationwide distribution across China's online and offline channels, marking a breakthrough for Korean cosmetics in the increasingly stringent Chinese market.
Caron Bio (search), a Korean scalp and hair loss (search) care specialist, has achieved a regulatory milestone by becoming the first Korean company to secure approval for a hair loss shampoo in China. The company's C3 Da Balmo Shampoo (search) successfully passed all required assessments from China's National Medical Products Administration (search) (NMPA), clearing the path for nationwide distribution across the world's second-largest economy.
Regulatory Breakthrough in Stringent Market
The approval represents a significant achievement given China's increasingly rigorous regulatory environment for special-purpose cosmetics. Since implementing the "Cosmetics Supervision and Management Regulations" in 2021, China has applied much stronger screening standards for products claiming special benefits such as whitening, UV protection, and hair loss (search) prevention.
The C3 shampoo underwent three core assessments mandated by Chinese regulators: a comprehensive toxicity test, human application test, and ingredient stability evaluation. With this approval, the product is now officially registered as a general cosmetic product, enabling legal distribution through both online and offline channels throughout China.
Clinical Efficacy Demonstrates Strong Results
The shampoo's regulatory success is backed by robust clinical data from German testing institute Dermatest. In a six-month clinical trial, the plant-based formulation demonstrated measurable improvements across multiple hair health parameters:
- Hair loss reduction of 54%
- New hair growth increase of 9%
- Resting-phase hair decrease of 10%
- Hair thickness improvement of 10%
- Hair density increase of 23%
The product uses plant-based ingredients designed to care for the scalp and strengthen hair roots. Beyond the German clinical validation, the shampoo's efficacy has been further supported by joint clinical studies conducted by research teams at Gangbuk Samsung Hospital (search) and Sungkyunkwan University, with findings published in international journals.
Market Entry Strategy and Global Expansion
Caron Bio (search) has already begun targeting Chinese consumers through Alibaba International T-Mall (search), with the regulatory approval now enabling expanded market penetration. The company views this milestone as establishing a stable sales foundation in China beyond simple export arrangements.
"This approval is the result of internationally recognizing the safety and efficacy of C3 products," said Cho Jin-hyeong, CEO of Caron Bio (search). "We will continue to develop products that meet global standards to lead the globalization of K-hair loss (search) solutions."
The company plans to leverage this regulatory success to accelerate its expansion strategy, with a promotional campaign scheduled for mid-September featuring a two-plus-one offer on all hair loss (search) products to celebrate the achievement.
Significance for Korean Cosmetics Industry
The approval marks a notable breakthrough for Korean cosmetics companies seeking to penetrate the Chinese market under increasingly stringent regulatory conditions. As the sole Korean hair loss (search) product to receive verification in the region, C3 shampoo's success may pave the way for other Korean cosmetics manufacturers to pursue similar regulatory pathways in China's lucrative beauty market.